Petrelintide
ZP8396
A long-acting human amylin analog studied in trials for weight management, engineered for stability and a dosing interval measured in days. Not approved.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
Not established in a public source. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Investigational; no approved label defines handling.
References
- PubChem compound record
- J Med Chem 2025: development of petrelintide, a potent, stable, long-acting human amylin analogue
Read the source
Related in GLP-1 / Metabolic
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.